Role of Replication Stress during Myc-dependent Lymphomagenesis
复制应激在 Myc 依赖性淋巴瘤发生过程中的作用
基本信息
- 批准号:8819518
- 负责人:
- 金额:$ 24.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-22 至 2017-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptive TransferAffectB-Cell LymphomasB-LymphocytesBiologicalBiological AssayBiologyCell ProliferationCellsCharacteristicsComplementary DNADNA DamageDNA biosynthesisDevelopmentDevelopment PlansDisciplineDiseaseEngineeringEnsureEnvironmentEpigenetic ProcessEventGene LibraryGenesGeneticGenetic TranscriptionGoalsGrowthHematopoietic stem cellsHumanIn VitroKnowledgeLesionLymphomaLymphomagenesisMalignant NeoplasmsMeasuresMentorsMolecularMusMutagenesisOncogene ActivationOncogenesOncogenicOpen Reading FramesOutcomePathway interactionsPhasePhenotypePhysiologicalProcessProteinsProto-OncogenesRelative (related person)Replication InitiationReporterResearchResearch Project GrantsRoleStressSystemSystems BiologyTechniquesTestingTissuesTrainingTranscriptional RegulationTransgenic MiceValidationVariantabstractingbasec-myc Genescancer initiationcancer therapycancer typecareer developmentcell transformationcopinghigh throughput technologyin vivoinsightinterestmouse modelmutantneoplastic cellnew therapeutic targetnoveloverexpressionresponsescreeningskillssuccesstherapeutic targettumortumor initiationtumor progressiontumorigenesistumorigenic
项目摘要
PROJECT SUMMARY/ABSTRACT (30 LINES)
Deregulated expression of the c-Myc protooncogene is a frequent requisite for the
development of many human cancers. Despite extensive knowledge of its biology, we are
still unaware of the precise molecular mechanisms that sustain its oncogenic activity.
Amplification of the physiologic control of DNA replication initiation by Myc upon
deregulation of its expression in primary cells and transgenic mouse B-cells causes
replication stress and subsequent DNA damage. Replication stress is a phenomenon
often seen in early cancers from different tissue origin, and it is believed to be
consequent to oncogene activation. However, formal proof for its requirement during
tumorigenesis is yet to be obtained. The long-term goal of this project is to characterize
the contribution of Myc-dependent replication stress to B-cell lymphomagenesis. We will
specifically assess whether altering Myc's ability to promote replication stress - by either
ablating its ability to control DNA replication or modifying the cellular responses to Myc-
dependent replication stress- determines the outcome of the oncogenic process. We
hypothesize that pathways coping with replication stress restrain tumor initiation driven
by this protooncogene and hence, manipulation of these pathways will determine Myc's
ability to generate lymphomas when deregulated in B-cells.
This Research Plan is meant to be part of a Career Development Plan through which I
aim to obtain critical knowledge and technical skills on: (1) the application of mouse
models to the study cancer initiation and progression; and (2) the use of high-
throughput technologies and Systems Biology to address general questions in the cancer
field that, due to their complexity, require integrated approaches. The extraordinary
characteristics of the host center, where all these disciplines are integrated for the study
of cancer, ensure an optimal environment for the training period. The mentored phase
will therefore allow me to transit with success to an independent phase, where to
continue to develop the final parts of this research project, obtain proof of principle for
the above proposed research hypothesis, and pursue the study of the basic mechanisms
of Myc-dependent B-cell lymphomagenesis, with aim to find novel therapeutic targets
for this group of diseases.
项目摘要/摘要(30行)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Dominguez-Sola其他文献
David Dominguez-Sola的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Dominguez-Sola', 18)}}的其他基金
Decay Accelerating Factor and B cell Immunity
衰变加速因子和 B 细胞免疫
- 批准号:
10406250 - 财政年份:2019
- 资助金额:
$ 24.41万 - 项目类别:
Decay Accelerating Factor and B cell Immunity
衰变加速因子和 B 细胞免疫
- 批准号:
10623288 - 财政年份:2019
- 资助金额:
$ 24.41万 - 项目类别:
Role of FOXO1 mutations in the pathogenesis of B cell non-Hodgkin lymphomas
FOXO1突变在B细胞非霍奇金淋巴瘤发病机制中的作用
- 批准号:
10334435 - 财政年份:2018
- 资助金额:
$ 24.41万 - 项目类别:
Role of FOXO1 mutations in the pathogenesis of B cell non-Hodgkin lymphomas
FOXO1突变在B细胞非霍奇金淋巴瘤发病机制中的作用
- 批准号:
10087895 - 财政年份:2018
- 资助金额:
$ 24.41万 - 项目类别:
ROLE OF REPLICATION STRESS DURING MYC-DEPENDENT LYMPHOMAGENESIS
复制应激在 MYC 依赖性淋巴细胞生成过程中的作用
- 批准号:
8146177 - 财政年份:2010
- 资助金额:
$ 24.41万 - 项目类别:
ROLE OF REPLICATION STRESS DURING MYC-DEPENDENT LYMPHOMAGENESIS
复制应激在 MYC 依赖性淋巴细胞生成过程中的作用
- 批准号:
7962386 - 财政年份:2010
- 资助金额:
$ 24.41万 - 项目类别:
Role of Replication Stress during Myc-dependent Lymphomagenesis
复制应激在 Myc 依赖性淋巴瘤发生过程中的作用
- 批准号:
8785173 - 财政年份:2010
- 资助金额:
$ 24.41万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 24.41万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 24.41万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 24.41万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 24.41万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 24.41万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 24.41万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 24.41万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 24.41万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 24.41万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 24.41万 - 项目类别:














{{item.name}}会员




